Analyst Summary
- Trinity Biotech received a notification from Nasdaq regarding non-compliance with Listing Rule 5450(a)(1), which requires a minimum bid price of US $1.00 per share.
- The company also received a notice for not meeting the requirement in Nasdaq Listing Rule 5450(b) to maintain a minimum market value of publicly held shares (MVPHS) of US $15,000,000.
- Trinity Biotech has until September 10, 2025, to regain compliance with both the minimum bid price and MVPHS requirements.
- The company’s ADSs will continue to trade on the Nasdaq Global Select Market under the symbol “TRIB” during the compliance period.
- Management intends to actively monitor the bid price and MVPHS and is evaluating options to regain compliance and maintain its listing.
- The company’s business operations are not affected by these notices.
Potential Implications
Stock Price
- Failure to regain compliance with Nasdaq listing requirements could lead to delisting from the Nasdaq Global Select Market.
- The stock price may be volatile during the compliance period as the company attempts to meet the minimum bid price and MVPHS requirements.